Jennifer D Portz1, Jean S Kutner1, Patrick J Blatchford2, Christine S Ritchie3. 1. Internal Medicine, School of Medicine, University of Colorado, Aurora, Colorado. 2. School of Public Health, University of Colorado, Aurora, Colorado. 3. Internal Medicine, University of California, San Francisco, San Francisco, California.
Abstract
OBJECTIVES: To enhance understanding of the relationship between multimorbidity, symptom burden, and functional status in individuals with life-limiting illness. DESIGN: Secondary analysis of baseline data from a randomized clinical trial conducted in the Palliative Care Research Cooperative Group. Group differences were tested using a t-test; multivariate regression analysis was used to determine the effect of multiple variables on functional status and symptom burden. SETTING: Fifteen Palliative Care Research Cooperation sites. PARTICIPANTS: Adults who participated in a parent statin-discontinuation clinical trial were included in the analysis (N = 381). Inclusion criteria were diagnosis of a life-limiting illness, statin use for 3 months or longer, life expectancy longer than 1 month, and declining functional status. MEASUREMENTS: Cancer diagnosis (solid organ and hematologic malignancies), multimorbidity (Charlson Comorbidity Index (CCI) score), symptom burden (Edmonton Symptom Assessment Scale (ESAS) score, number of symptoms with ESAS severity score >4), functional status (Australia-modified Karnofsky Performance Scale (AKPS)). RESULTS:Fifty-one percent had a primary diagnosis of cancer; mean age 74.1 ± 11.6. Participants had multiple comorbid illnesses (CCI score 4.9 ± 2.8), multiple symptoms (ESAS score 27.2 ± 15.9), and poor functional status (AKPS = 53 ± 13). In univariate and multivariate analyses, multimorbidity was associated with greater symptom burden (4.2 vs 3.1 moderate or severe symptoms (t = -3.2, P = .002), 12% vs 6% with severe symptoms (t = -3.7, P < .001)), but cancer diagnosis was not. In univariate and multivariate analyses, higher symptom burden was associated with poorer functional status (F = 11.6, P < .001), but multimorbidity was not. CONCLUSION: Symptoms cannot be attributed solely to a diagnosis of cancer. The association between symptom burden and functional status underscores the importance of clinical attention to symptoms in individuals with multimorbidity.
RCT Entities:
OBJECTIVES: To enhance understanding of the relationship between multimorbidity, symptom burden, and functional status in individuals with life-limiting illness. DESIGN: Secondary analysis of baseline data from a randomized clinical trial conducted in the Palliative Care Research Cooperative Group. Group differences were tested using a t-test; multivariate regression analysis was used to determine the effect of multiple variables on functional status and symptom burden. SETTING: Fifteen Palliative Care Research Cooperation sites. PARTICIPANTS: Adults who participated in a parent statin-discontinuation clinical trial were included in the analysis (N = 381). Inclusion criteria were diagnosis of a life-limiting illness, statin use for 3 months or longer, life expectancy longer than 1 month, and declining functional status. MEASUREMENTS: Cancer diagnosis (solid organ and hematologic malignancies), multimorbidity (Charlson Comorbidity Index (CCI) score), symptom burden (Edmonton Symptom Assessment Scale (ESAS) score, number of symptoms with ESAS severity score >4), functional status (Australia-modified Karnofsky Performance Scale (AKPS)). RESULTS: Fifty-one percent had a primary diagnosis of cancer; mean age 74.1 ± 11.6. Participants had multiple comorbid illnesses (CCI score 4.9 ± 2.8), multiple symptoms (ESAS score 27.2 ± 15.9), and poor functional status (AKPS = 53 ± 13). In univariate and multivariate analyses, multimorbidity was associated with greater symptom burden (4.2 vs 3.1 moderate or severe symptoms (t = -3.2, P = .002), 12% vs 6% with severe symptoms (t = -3.7, P < .001)), but cancer diagnosis was not. In univariate and multivariate analyses, higher symptom burden was associated with poorer functional status (F = 11.6, P < .001), but multimorbidity was not. CONCLUSION: Symptoms cannot be attributed solely to a diagnosis of cancer. The association between symptom burden and functional status underscores the importance of clinical attention to symptoms in individuals with multimorbidity.
Authors: Martin Fortin; Gina Bravo; Catherine Hudon; Lise Lapointe; José Almirall; Marie-France Dubois; Alain Vanasse Journal: Qual Life Res Date: 2006-02 Impact factor: 4.147
Authors: Vera Weingaertner; Christine Scheve; Verena Gerdes; Michael Schwarz-Eywill; Regina Prenzel; Claudia Bausewein; Irene J Higginson; Raymond Voltz; Lena Herich; Steffen T Simon Journal: J Pain Symptom Manage Date: 2014-03-12 Impact factor: 3.612
Authors: Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie Journal: Lancet Date: 2012-05-10 Impact factor: 79.321
Authors: Amy P Abernethy; Tania Shelby-James; Belinda S Fazekas; David Woods; David C Currow Journal: BMC Palliat Care Date: 2005-11-12 Impact factor: 3.234
Authors: Linda Pang; Maxine de la Cruz; Jimin Wu; Diane Liu; Mujtaba Naqvi; Eduardo Bruera Journal: Support Care Cancer Date: 2019-02-23 Impact factor: 3.603
Authors: Komal P Murali; Gary Yu; John D Merriman; Allison Vorderstrasse; Amy S Kelley; Abraham A Brody Journal: Nurs Res Date: 2021 Nov-Dec 01 Impact factor: 2.381
Authors: Komal P Murali; Gary Yu; John D Merriman; Allison Vorderstrasse; Amy S Kelley; Abraham A Brody Journal: West J Nurs Res Date: 2021-08-25 Impact factor: 1.967
Authors: A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni Journal: J Intern Med Date: 2018-11-22 Impact factor: 8.989
Authors: Atul Batra; Lin Yang; Devon J Boyne; Andrew Harper; Winson Y Cheung; Colleen A Cuthbert Journal: Support Care Cancer Date: 2020-07-16 Impact factor: 3.603
Authors: Melissa Mazor; Steven M Paul; Margaret A Chesney; Lee-May Chen; Betty Smoot; Kimberly Topp; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Cancer Date: 2019-09-10 Impact factor: 6.860
Authors: Komal Patel Murali; John D Merriman; Gary Yu; Allison Vorderstrasse; Amy Kelley; Abraham A Brody Journal: Am J Hosp Palliat Care Date: 2020-06-08 Impact factor: 2.500
Authors: Jongmin Park; Nada Lukkahatai; Nancy Perrin; Yoonju Kim; Leorey N Saligan; Chang Won Won Journal: Int J Environ Res Public Health Date: 2021-02-11 Impact factor: 3.390
Authors: Jeanne S Mandelblatt; Wanting Zhai; Jaeil Ahn; Brent J Small; Tim A Ahles; Judith E Carroll; Neelima Denduluri; Asma Dilawari; Martine Extermann; Deena Graham; Arti Hurria; Claudine Isaacs; Paul B Jacobsen; Heather S L Jim; George Luta; Brenna C McDonald; Sunita K Patel; James C Root; Andrew J Saykin; Danielle B Tometich; Xingtao Zhou; Harvey J Cohen Journal: Cancer Date: 2019-12-20 Impact factor: 6.921